Related Experiment Video
Updated: Aug 9, 2026

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
Published on: January 22, 2021
Coexpression of CD43 by benign B cells in the terminal ileum
Po-Shing Lee1, Debra Beneck, James Weisberger
1From Division of Hematopathology, IMPATH Inc, New York, NY 10019, USA.
Insights
CD43 expression on B cells can indicate lymphoproliferative disorders. However, benign B cells in the terminal ileum frequently express CD43, making it unreliable for diagnosing MALT lymphoma versus reactive conditions.
Area of Science:
- Immunohistochemistry
- B-cell lymphomas
- Gastrointestinal pathology
Background:
- CD43 expression on B cells is a diagnostic marker for B-cell lymphoproliferative disorders.
- Benign B cells typically do not coexpress CD43.
- Distinguishing extranodal marginal zone B-cell lymphoma of MALT type from reactive processes can be challenging.
Purpose of the Study:
- To investigate CD43 expression in benign B cells within the terminal ileum.
- To determine if CD43 coexpression in the terminal ileum is a reliable indicator of B-cell lymphoproliferative disorders.
Main Methods:
- Analysis of 20 terminal ileum biopsies for nonneoplastic disease.
- Assessment of CD43 expression alongside CD20, CD138, and CD3 reactivity.
- Comparison of CD43 expression in the terminal ileum with other anatomical sites.
Main Results:
- 85% of cases showed strong CD43 coexpression in benign perifollicular B cells.
- Benign B cells in the terminal ileum, including Peyer's patches, frequently express CD43.
- CD43 coexpression was observed in benign B-cell populations.
Conclusions:
- CD43 coexpression in terminal ileum B cells, including Peyer's patches, is common in benign conditions.
- CD43 should not be used as a sole diagnostic marker to differentiate MALT lymphoma from reactive processes in the terminal ileum.
Abstract:
Expression of CD43 by B cells is often used as a diagnostic criterion in favor of a B-cell lymphoproliferative disorder, including small lymphocytic lymphoma/chronic lymphocytic leukemia, mantle cell lymphoma, Burkitt lymphoma, precursor B-lymphoblastic lymphoma, and a subset of marginal zone B-cell lymphomas. Benign B cells generally do not coexpress CD43. The authors analyzed 20 biopsies of the terminal ileum for nonneoplastic disease for expression of CD43 and compared them with other sites and with CD20, CD138, and CD3 reactivity. The majority of cases (85%) showed strong coexpression of CD43 by benign perifollicular B cells. The presence of CD43 coexpression in B-cell populations of the terminal ileum, including those of Peyer's patches, should not be used as a diagnostic parameter to differentiate extranodal marginal zone B-cell lymphoma of MALT type from reactive processes.
Related Concept Videos
Renewal of Intestinal Stem Cells
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease

